Hinova Pharmaceuticals Inc.
Clinical trials sponsored by Hinova Pharmaceuticals Inc., explained in plain language.
-
New pill aims to shrink dangerous liver fat
Disease control Recruiting nowThis study is testing a new oral medication called HP515 to see if it can safely reduce the amount of fat in the liver of people with non-alcoholic fatty liver disease (NAFLD). About 80 participants will take either the HP515 tablet or a placebo (a dummy pill) for 12 weeks. Resea…
Phase: PHASE2 • Sponsor: Hinova Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New oral drug trial offers hope for advanced prostate cancer patients
Disease control Recruiting nowThis early-stage study is testing a new oral medication called HP518 for men with advanced prostate cancer that has spread and stopped responding to standard treatments. The trial aims to find the safest and most effective dose while checking if the drug can reduce cancer markers…
Phase: PHASE1, PHASE2 • Sponsor: Hinova Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC